Department of Neurosurgery, The Johns Hopkins University School of Medicine, Bethesda, Maryland, USA.
Department of Neurosurgery, The Johns Hopkins University School of Medicine, Bethesda, Maryland, USA; Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Bethesda, Maryland, USA.
World Neurosurg. 2020 Jul;139:e877-e884. doi: 10.1016/j.wneu.2020.05.167. Epub 2020 May 24.
Coronavirus disease 2019 (COVID-19) is a disruptive pandemic that has continued to test the limits of health care system capacities. It is important to highlight the specific challenges facing US neurosurgery during these difficult circumstances. In the present study, we have described our neurosurgery department's unique experience during the COVID-19 pandemic.
We analyzed the following data points both before and during the first months of the COVID-19 pandemic: the number of patients infected with COVID-19 at our institution, changes in neurosurgical operative workflow, changes in neurosurgical outpatient and inpatient clinic workflows, resident redeployment statistics and changes in call schedules, and changes in neurosurgical education.
At our institution, the adult surgery numbers decreased from 120 during the week of March 4-11, 2020 (before the World Health Organization had classified the COVID-19 outbreak as a pandemic) to 17 during the week of April 13-17, 2020. The number of pediatric surgeries decreased from 15 to 3 during the same period. Significantly more surgeries were cancelled than were delayed (P < 0.0001). A drastic decline occurred in the number of in-person neurosurgery clinic visits (97.12%) between March and April 2020 (P = 0.0020). The inpatient census declined from mid-March to mid-April 2020 by 44.68% compared with a 4.26% decline during the same period in 2019 (P < 0.0001). Finally, neurosurgery education has largely shifted toward video-conferencing sessions rather than in-person sessions.
By detailing our experience during the COVID-19 pandemic, we hope to have provided a detailed picture of the challenges facing neurosurgery within an academic medical center.
2019 年冠状病毒病(COVID-19)是一场具有破坏性的大流行疫情,它不断考验着医疗体系能力的极限。在困难时期,突出美国神经外科学面临的具体挑战非常重要。在本研究中,我们描述了 COVID-19 大流行期间我们神经外科部门的独特经验。
我们分析了 COVID-19 大流行前后以下数据点:我们机构感染 COVID-19 的患者数量、神经外科手术流程的变化、神经外科门诊和住院患者流程的变化、住院医师重新部署统计数据和呼叫时间表的变化以及神经外科学教育的变化。
在我们的机构中,成人手术数量从 2020 年 3 月 4 日至 11 日的一周内的 120 例减少到 4 月 13 日至 17 日的一周内的 17 例。同期儿科手术数量从 15 例减少到 3 例。取消的手术数量明显多于推迟的手术数量(P<0.0001)。2020 年 3 月至 4 月期间,神经外科门诊就诊人数急剧下降(97.12%)(P=0.0020)。与 2019 年同期相比,2020 年 3 月至 4 月期间住院患者人数减少了 44.68%(P<0.0001)。最后,神经外科学教育在很大程度上转向了视频会议,而不是面对面会议。
通过详细描述我们在 COVID-19 大流行期间的经验,我们希望提供了一幅关于学术医疗中心内神经外科面临的挑战的详细画面。